Vista Pharma, a company in the Pharmaceuticals industry, reported revenue of ₹2.42 crore and a net loss of ₹2.32 crore for the December 2025 quarter.
Vista Pharma. (BSE: VISTAPH) closed at ₹6.25 on 20 Nov 2026, down 27.5% over the past year. Its market capitalisation is ₹38 crore.
Incorporated in 1992, Vista Pharmaceuticals Ltd manufactures and sells pharmaceutical, medical and veterinary preparations
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.